Los puntos clave no están disponibles para este artículo en este momento.
The developed method could be potentially highly useful on interpreting classification results in the context of different omics data and prior knowledge molecular networks on the individual patient level, as for example in precision medicine approaches or a molecular tumor board.
Chereda et al. (Thu,) studied this question.